Institute of Liver and Gastrointestinal Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.
Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.
Signal Transduct Target Ther. 2021 Nov 8;6(1):379. doi: 10.1038/s41392-021-00778-y.
In recent years, accumulating evidence has elucidated the role of lysosomes in dynamically regulating cellular and organismal homeostasis. Lysosomal changes and dysfunction have been correlated with the development of numerous diseases. In this review, we interpreted the key biological functions of lysosomes in four areas: cellular metabolism, cell proliferation and differentiation, immunity, and cell death. More importantly, we actively sought to determine the characteristic changes and dysfunction of lysosomes in cells affected by these diseases, the causes of these changes and dysfunction, and their significance to the development and treatment of human disease. Furthermore, we outlined currently available targeting strategies: (1) targeting lysosomal acidification; (2) targeting lysosomal cathepsins; (3) targeting lysosomal membrane permeability and integrity; (4) targeting lysosomal calcium signaling; (5) targeting mTOR signaling; and (6) emerging potential targeting strategies. Moreover, we systematically summarized the corresponding drugs and their application in clinical trials. By integrating basic research with clinical findings, we discussed the current opportunities and challenges of targeting lysosomes in human disease.
近年来,越来越多的证据阐明了溶酶体在动态调节细胞和机体稳态中的作用。溶酶体的变化和功能障碍与许多疾病的发展有关。在这篇综述中,我们从四个方面解释了溶酶体的关键生物学功能:细胞代谢、细胞增殖和分化、免疫和细胞死亡。更重要的是,我们积极寻求确定受这些疾病影响的细胞中溶酶体的特征变化和功能障碍、这些变化和功能障碍的原因,以及它们对人类疾病发展和治疗的意义。此外,我们概述了目前可用的靶向策略:(1)靶向溶酶体酸化;(2)靶向溶酶体组织蛋白酶;(3)靶向溶酶体膜通透性和完整性;(4)靶向溶酶体钙信号;(5)靶向 mTOR 信号;以及(6)新兴的潜在靶向策略。此外,我们还系统地总结了相应的药物及其在临床试验中的应用。通过将基础研究与临床发现相结合,我们讨论了在人类疾病中靶向溶酶体的当前机遇和挑战。